Investors
News Release
BIO GREEN MED SOLUTION REPORTS THIRD QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
Nov 12 2026
Highlights of the third quarter ended
- In October, the Company’s previously filed Form S-4, detailing the Company’s proposed Business Combination Agreement with
Future NRG Sdn. Bhd ., aMalaysia private limited company, was declared effective. The Company is planning to hold a Special Meeting inNovember 2026 to obtain shareholder approval for the proposed Business Combination. - In October, the Board of Directors of the Company declared a quarterly cash dividend of
$0.15 per share on the Company’s 6% Convertible Exchangeable Preferred Stock, which cash dividend was paid onNovember 1, 2026 , to holders of record as of the close of business onOctober 26, 2026 .
“During the third quarter, our fire safety business generated
Financial Highlights
As of
Net cash used in operating activities was
Following the acquisition of
Cost of sales related to sales and distribution of fire safety equipment was
General and administrative expenses decreased by approximately
Total other income, net, for the three months ended
Income tax provision for the three months ended
Net loss from discontinued operations was
Net loss for the three months ended
About Bio Green Med Solution, Inc.
BGMS is a diversified company that was formerly engaged in the biopharmaceutical industry but as of September 2025 has shifted its operations to focus on provision of fire safety protection and distribution activities. Specifically, on September 12, 2025, the Company completed its acquisition of Fitters Sdn. Bhd., a Malaysia-based group specializing in fire protection products and services. The Company is now focused on advancing opportunities across these distinct sectors whilst maintaining its commitment to driving long-term value creation for shareholders. For additional information, please visit www.bgmsglobal.com.
Forward-looking Statements
Except for historical information, certain matters discussed in this press release may be “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These statements relate to future events or our future financial performance and involve various assumptions, known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements by words such as “may,” “will,” “should,” “expects,” “intends,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential” or other comparable words. Actual results, performance or outcomes may differ materially from those expressed or implied by these forward-looking statements and may not align with historical performance and events due to a number of factors, including those discussed in the sections of our annual report on Form 10-K entitled “Cautionary Statement Regarding Forward-Looking Statements” and “Risk Factors,” and those discussed in our Form 10-Q quarterly reports filed after such annual report. BGMS’s SEC filings are readily obtainable at no charge at www.sec.gov, as well as on its own investor relations website at https://investor.bgmsglobal.com/sec-filings. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements, and caution should be exercised against placing undue reliance upon such statements, which are based only on information currently available to us and speak only as of the date hereof. We are under no duty to update publicly any of the forward-looking statements after the date of this earnings press release, whether as a result of new information, future events or otherwise, except as required by law.
SOURCE:
Bio Green Med Solution, Inc.
info@bgmsglobal.com
BIO GREEN MED SOLUTION, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS (LOSS)
(In $000s, except share and per share amounts)
| Three Months Ended | ||||||||
| 2026 | 2025 | |||||||
| Revenues: | ||||||||
| Product revenue - fire safety | $ | 454 | $ | 81 | ||||
| Revenues | $ | 454 | $ | 81 | ||||
| Operating expenses: | ||||||||
| Cost of sales | 339 | 64 | ||||||
| General and administrative | 635 | 1,004 | ||||||
| Total operating expenses | 974 | 1,068 | ||||||
| Operating loss | (520 | ) | (987 | ) | ||||
| Other income (expense): | ||||||||
| Foreign exchange (losses) | (3 | ) | (14 | ) | ||||
| Interest income | 44 | 9 | ||||||
| Other income, net | 33 | 9 | ||||||
| Total other income, net | 74 | 4 | ||||||
| Loss from continuing operations before taxes | (446 | ) | (983 | ) | ||||
| Income tax provision | (3 | ) | - | |||||
| Net loss from continuing operations | (449 | ) | (983 | ) | ||||
| Discontinued operations: | ||||||||
| Operating losses from discontinued operations | - | (5 | ) | |||||
| Net income from discontinued operations | - | (5 | ) | |||||
| Net loss | (449 | ) | (988 | ) | ||||
| Dividend on convertible exchangeable preferred shares | (20 | ) | (21 | ) | ||||
| Deemed dividend on warrant exchange | - | (1,494 | ) | |||||
| Net loss applicable to common shareholders | $ | (469 | ) | $ | (2,503 | ) | ||
| Basic and diluted earnings per common share: | ||||||||
| Net loss per share, continuing operations – basic and diluted (common shareholders) | $ | (0.07 | ) | $ | (1.31 | ) | ||
| Net income per share, discontinued operations – basic and diluted (common shareholders) | $ | (0.00 | ) | $ | (0.00 | ) | ||
| Net loss per share – basic and diluted (common shareholders) | $ | (0.07 | ) | $ | (1.31 | ) | ||
| Weighted average common shares outstanding | 6,622,794 | 1,912,495 | ||||||
CONSOLIDATED BALANCE SHEET
(In $000s, except share, per share, and liquidation preference amounts)
| 2026 | 2025 | |||||||
| ASSETS | ||||||||
| Current assets: | ||||||||
| Cash and cash equivalents | $ | 3,454 | $ | 3,505 | ||||
| Accounts receivable | 974 | 1,257 | ||||||
| Inventory | 991 | 1,384 | ||||||
| Prepaid expenses and other current assets | 158 | 110 | ||||||
| Total current assets | 5,577 | 6,256 | ||||||
| Property and equipment, net Property and equipment, net | 134 | 137 | ||||||
| Right-of-use lease asset | 5 | 12 | ||||||
| Goodwill | 1,570 | 1,570 | ||||||
| Property and equipment, net Non-current assets | 192 | 210 | ||||||
| Total assets | $ | 7,478 | $ | 8,185 | ||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||
| Current liabilities: | ||||||||
| Accounts payable | $ | 181 | $ | 617 | ||||
| Accrued and other current liabilities | 634 | 715 | ||||||
| Total current liabilities | 815 | 1,332 | ||||||
| Lease liability | - | 2 | ||||||
| Other liabilities | 2 | 9 | ||||||
| Total liabilities | 817 | 1,343 | ||||||
| Stockholders’ equity | 6,661 | 6,842 | ||||||
| Total liabilities and stockholders’ equity | $ | 7,478 | $ | 8,185 | ||||
Source: Bio Green Med Solution, Inc.